Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP734924.RAA7qMKpUS24ugtJ_aX9di5wCWZEXMbEdi_fLNH1W6zRk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP734924.RAA7qMKpUS24ugtJ_aX9di5wCWZEXMbEdi_fLNH1W6zRk130_assertion type Assertion NP734924.RAA7qMKpUS24ugtJ_aX9di5wCWZEXMbEdi_fLNH1W6zRk130_head.
- NP734924.RAA7qMKpUS24ugtJ_aX9di5wCWZEXMbEdi_fLNH1W6zRk130_assertion wasGeneratedBy ECO_0000203 NP734924.RAA7qMKpUS24ugtJ_aX9di5wCWZEXMbEdi_fLNH1W6zRk130_provenance.
- NP734924.RAA7qMKpUS24ugtJ_aX9di5wCWZEXMbEdi_fLNH1W6zRk130_assertion wasDerivedFrom befree-20150227 NP734924.RAA7qMKpUS24ugtJ_aX9di5wCWZEXMbEdi_fLNH1W6zRk130_provenance.
- NP734924.RAA7qMKpUS24ugtJ_aX9di5wCWZEXMbEdi_fLNH1W6zRk130_assertion SIO_000772 21515839 NP734924.RAA7qMKpUS24ugtJ_aX9di5wCWZEXMbEdi_fLNH1W6zRk130_provenance.
- NP734924.RAA7qMKpUS24ugtJ_aX9di5wCWZEXMbEdi_fLNH1W6zRk130_assertion evidence source_evidence_literature NP734924.RAA7qMKpUS24ugtJ_aX9di5wCWZEXMbEdi_fLNH1W6zRk130_provenance.
- NP734924.RAA7qMKpUS24ugtJ_aX9di5wCWZEXMbEdi_fLNH1W6zRk130_assertion description "[A total of 150 infants with a first-degree family history of type 1 diabetes and a risk HLA genotype were randomly assigned to a first gluten exposure at age 6 months (control group) or 12 months (late-exposure group) and were followed 3 monthly until the age of 3 years and yearly thereafter for safety (for growth and autoantibodies to transglutaminase C [TGCAs]), islet autoantibodies to insulin, GAD, insulinoma-associated protein 2, and type 1 diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP734924.RAA7qMKpUS24ugtJ_aX9di5wCWZEXMbEdi_fLNH1W6zRk130_provenance.